Patents by Inventor Ziwei Yun

Ziwei Yun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9186318
    Abstract: Provided in the present invention is a quinolyl-containing hydroxamic acid compound as shown in formula (I), at the same time also disclosed is the preparation method of the compound and the use thereof, and a pharmaceutical composition containing the quinolyl-containing hydroxamic acid compound. Such compounds are inhibitors of protein kinases and/or histone deacetylases, and can be used in the treatment of diseases caused by the abnormal activity of protein kinases and/or histone deacetylases, for example, tumors, etc.
    Type: Grant
    Filed: September 27, 2011
    Date of Patent: November 17, 2015
    Assignee: Beijing Konruns Pharmaceutical Co., Ltd
    Inventors: Ziwei Yun, Hongtao Wang
  • Patent number: 8933230
    Abstract: Phosphorus-containing group-substituted quinolines of formula (I) are provided in the present invention. The preparation process and application of the compound, and formulation comprising phosphorus-containing group-substituted quinolines are also disclosed. The compounds are protein kinase inhibitor and can be used for treating protein kinase abnormal activity-associated diseases, such as tumor, etc.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: January 13, 2015
    Assignee: Beijing Konruns Pharmaceutical Co., Ltd.
    Inventors: Ziwei Yun, Hongtao Wang
  • Publication number: 20140221425
    Abstract: Provided in the present invention is a quinolyl-containing hydroxamic acid compound as shown in formula (I), at the same time also disclosed is the preparation method of the compound and the use thereof, and a pharmaceutical composition containing the quinolyl-containing hydroxamic acid compound. Such compounds are inhibitors of protein kinases and/or histone deacetylases, and can be used in the treatment of diseases caused by the abnormal activity of protein kinases and/or histone deacetylases, for example, tumors, etc.
    Type: Application
    Filed: September 27, 2011
    Publication date: August 7, 2014
    Applicant: BEIJING KONRUNS PHARMACEUTICAL CO., LTD.
    Inventors: Ziwei Yun, Hongtao Wang
  • Publication number: 20130331359
    Abstract: Phosphorus-containing group-substituted quinolines of formula (I) are provided in the present invention. The preparation process and application of the compound, and formulation comprising phosphorus-containing group-substituted quinolines are also disclosed. The compounds are protein kinase inhibitor and can be used for treating protein kinase abnormal activity-associated diseases, such as tumor, etc.
    Type: Application
    Filed: April 6, 2011
    Publication date: December 12, 2013
    Applicant: BEIJING KONRUNS PHARMACEUTICAL CO., LTD.
    Inventors: Ziwei Yun, Hongtao Wang